Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IITerminatedD-1045-2019

Drug recall · March 27, 2019

Losartan Potassium and Hydrochlorothiazide Tablets recall

Why: CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50 mg/12.5 mg 50 Tablets (5x10) Unit Dose boxes, Rx Only Manufactured for: AvKARE Inc. Pulaski, TN 38478 --- NDC 50268-513-15

Lots / codes

Lot: 19454 Exp. 04/30/2019

Quantity
N/A
Company
AVKARE Inc., Pulaski, TN
Distribution
Nationwide.
Initiated
March 5, 2019 · Voluntary: Firm initiated
Classified
March 21, 2019
Reported
March 27, 2019
Ended
December 7, 2020
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Recalled with it (same recall event)

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Losartan

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.